Home > Result Summaries: Compounds > Hepatitis B Vaccine, Recombinant > Result Summary for 106744

Result Summary for 106744

Result Summary

Protocol ID:	106744
Clinical Study ID:	106744
Official Title:	Multicentre study to assess persistence of antibodies against hepatitis B & immune response to a hepatitis B challenge dose in healthy children 7 to 9 yrs old previously vaccinated with 4 doses of GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine
Phase:	phase 4
Study Indications or Diseases:	Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis Vaccines
Generic Name:	Hepatitis B Vaccine, Recombinant
Trade/Product Name:	Engerix-B
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Zinke M et al. Immune memory against hepatitis B persists in 7-9 year olds previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine. Abstract presented at the 26th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID), Graz, Austria, 13-17 May 2008. Zinke M et al. Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib. Abstract presented at the 26th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID), Graz, Austria, 13-17 May 2008.